{"meta":{"query_hash":"04f5eb14efce","filters":{"venue":"Journal of Biomedicine and Translational Research"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/04f5eb14efce","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Biomedicine+and+Translational+Research"},"results":[{"id":"W3090716446","doi":"10.14710/jbtr.v6i1.7321","title":"Fragile X Syndrome and Targeted Treatments","year":2020,"lang":"en","type":"article","venue":"Journal of Biomedicine and Translational Research","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Azrieli Foundation; Zynerba Pharmaceuticals; Intellectual and Developmental Disabilities Research Center; National Fragile X Foundation","keywords":"Fragile X syndrome; Fragile x; FMR1; Medicine; Medical prescription; Psychiatry; Pharmacology; Genetics; Biology","score_opus":0.04550665046927028,"score_gpt":0.3306426971992499,"score_spread":0.2851360467299796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090716446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035801684,0.94206357,0.0016207522,0.024027262,0.0016931714,0.000034431534,0.00013924175,0.000070940114,0.026770364],"genre_scores_gemma":[0.03580242,0.92509633,0.0030020918,0.01552272,0.0027094043,0.00011619981,0.00021238154,0.000019316429,0.017519183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972445,0.00007640258,0.00001907978,0.000049580452,0.00009626061,0.000034239056],"domain_scores_gemma":[0.9998381,0.00006759515,0.00003204671,0.000010346082,0.00002609084,0.00002573047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053508976,0.00050337374,0.00042675447,0.00066956773,0.0003520103,0.00073282875,0.00033706237,0.0014125139,0.004153172],"category_scores_gemma":[0.00071248435,0.000093672716,0.00040481013,0.00031357282,0.0008213041,0.00069030956,0.0006959046,0.0015882454,0.00094347226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002799101,0.00017923629,0.001740463,0.0026359071,0.00016600107,0.0020534978,0.00024333372,0.0004138366,0.0054122997,0.07672009,0.10119933,0.80895615],"study_design_scores_gemma":[0.000093418654,0.00038811273,0.003921288,0.0027656222,0.00010499446,0.008648396,0.0001614382,0.00013892788,0.0019626196,0.03361022,0.94816893,0.000036080524],"about_ca_topic_score_codex":0.0012901151,"about_ca_topic_score_gemma":0.0020949964,"teacher_disagreement_score":0.004153172,"about_ca_system_score_codex":0.0010736592,"about_ca_system_score_gemma":0.00077617867,"threshold_uncertainty_score":0.0138937235},"labels":[],"label_agreement":null}]}